Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$6.65M Buy
197,579
+5,730
+3% +$197K 1.82% 10
2017
Q4
$6.59M Buy
191,849
+4,627
+2% +$158K 1.76% 12
2017
Q3
$6.34M Buy
187,222
+20,314
+12% +$653K 1.74% 13
2017
Q2
$5.32M Buy
166,908
+1,663
+1% +$52.4K 1.49% 14
2017
Q1
$5.36M Sell
165,245
-2,068
-1% -$65.2K 1.52% 15
2016
Q4
$5.16M Sell
167,313
-1,236
-0.7% -$37.7K 1.5% 15
2016
Q3
$5.42M Buy
168,549
+1,497
+0.9% +$50.1K 1.65% 14
2016
Q2
$5.58M Buy
167,052
+415
+0.2% +$13.2K 1.74% 12
2016
Q1
$4.69M Buy
166,637
+2,820
+2% +$80.6K 1.5% 15
2015
Q4
$5.02M Buy
+163,817
New +$5.15M 1.65% 13

Other funds holding PFE

Argent Trust's PFE Position: Q1 2018 in Review

Argent Trust increased its Pfizer (PFE) stake by 3% in Q1 2018, buying an estimated $197K and bringing the position to 197,579 shares worth $6.65M. The position accounts for 1.82% of the portfolio, ranked #10.

Argent Trust first reported a position in PFE in Q4 2015 and has held it in 10 quarters since. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Argent Trust held 197,579 shares of Pfizer worth $6.65M as of Q1 2018.
  • Argent Trust bought 5,730 Pfizer shares in Q1 2018, an estimated $197K.
  • Pfizer made up 1.82% of Argent Trust's portfolio in Q1 2018, its #10 holding.
  • Argent Trust first reported a position in Pfizer in Q4 2015 and has held it in 10 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.